Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC

Clinical trial NCT05261438 · COMPLETED

Trial details

NCT number: NCT05261438
Sponsor: Hunan Province Tumor Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Non-squamous NSCLC

Start date: 2019-09-01
Primary completion: 2021-05-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.